A GLP-1 Analog Liraglutide Reduces Intimal Hyperplasia After Coronary Stent Implantation via Regulation of Glycemic Variability and NLRP3 Inflammasome/IL-10 Signaling in Diabetic Swine
ObjectiveThis study aimed to explore whether treatment with the glucagon-like peptide-1 (GLP-1) analog liraglutide reduces intimal hyperplasia after coronary stent implantation via regulation of glycemic variability, the NLRP3 inflammasome, and IL-10 in diabetic swine.MethodsFifteen pigs were divide...
Main Authors: | Jinggang Xia, Qinxue Li, Yayun Liu, Quanxin Ren, Jinhuan Gao, Yi Tian, Jubo Li, Baojie Zhang, Haichen Sun, Shuang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00372/full |
Similar Items
-
Insulin Reduces Inflammation by Regulating the Activation of the NLRP3 Inflammasome
by: Yu-Wei Chang, et al.
Published: (2021-02-01) -
NLRP3 Inflammasome Mediates Dormant Neutrophil Recruitment following Sterile Lung Injury and Protects against Subsequent Bacterial Pneumonia in Mice
by: Xiaoli Tian, et al.
Published: (2017-10-01) -
Remdesivir Alleviates Acute Kidney Injury by Inhibiting the Activation of NLRP3 Inflammasome
by: Liang Yin, et al.
Published: (2021-05-01) -
Sialylated human milk oligosaccharides prevent intestinal inflammation by inhibiting toll like receptor 4/NLRP3 inflammasome pathway in necrotizing enterocolitis rats
by: Wenting Zhang, et al.
Published: (2021-01-01) -
Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation
by: Li P, et al.
Published: (2020-04-01)